Qiang Wei

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 62

Top Topics

Benign Prostatic Hyperplasia

Systematic Review

Magnetic Resonance Imaging

Top Venues

Cancer medicine

Research square

World journal of urology

This page only lists publications with an associated author ORCID identifier.

Publications

Shiyu Zhang, Tianhai Lin, Xingyu Xiong, Chong Chen, Ping Tan, Qiang Wei
Targeting histone modifiers in bladder cancer therapy - preclinical and clinical evidence. Nature reviews. Urology 21 (8) (2024)
Chichen Zhang, Xiang Tu, Jindong Dai, Zilong Zhang, Chenlan Shen, Qiyou Wu, Zhenhua Liu, Tianhai Lin, Shi Qiu, Lu Yang, Ling Yang, Mengni Zhang, Diming Cai, Yige Bao, Hao Zeng, Qiang Wei
Utilization trend of prebiopsy multiparametric magnetic resonance imaging and its impact on prostate cancer detection: Real-world insights from a high-volume center in southwest China. The Prostate (2024)
Jie Yang, Xingyu Xiong, Qiang Wei, Lu Yang
Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer. BJU international (2024)
Bo Chen, Pengfei Xu, Joy C Yang, Christopher Nip, Leyi Wang, Yuqiu Shen, Shu Ning, Yufeng Shang, Eva Corey, Allen C Gao, Jason E Gestwicki, Qiang Wei, Liangren Liu, Chengfei Liu
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Oncogene 43 (30) (2024)
Bo Chen, Pengfei Xu, Joy C Yang, Christopher Nip, Leyi Wang, Yuqiu Shen, Shu Ning, Yufeng Shang, Eva Corey, Allen C Gao, Jason E Gestwicki, Qiang Wei, Liangren Liu, Chengfei Liu
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Oncogene 43 (30) (2024)
Chengfei Liu, Bo Chen, Pengfei Xu, Joy C Yang, Christopher Nip, Leyi Wang, Yuqiu Shen, Shu Ning, Yufeng Shang, Eva Corey, Allen C Gao, Jason E Gestwicki, Qiang Wei, Liangren Liu
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Research square (2024)
Feng Wen, Tianhai Lin, Peng Zhang, Hao Zeng, Qiang Wei, Yali Shen
Bladder sparing by short-course radiotherapy combined with toripalimab in high-risk/extremely high-risk non-muscle invasive bladder cancer (HOPE-04): study protocol for a single-arm, prospective, phase II trial. BMJ open 14 (1) (2024)
Bo Chen, Pengfei Xu, Joy C Yang, Christopher Nip, Leyi Wang, Yuqiu Shen, Shu Ning, Yufeng Shang, Eva Corey, Allen C Gao, Jason E Gestwicki, Qiang Wei, Liangren Liu, Chengfei Liu
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Oncogene 43 (30) (2024)
Chengfei Liu, Bo Chen, Pengfei Xu, Joy C Yang, Christopher Nip, Leyi Wang, Yuqiu Shen, Shu Ning, Yufeng Shang, Eva Corey, Allen C Gao, Jason E Gestwicki, Qiang Wei, Liangren Liu
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Research square (2024)
Bo Chen, Pengfei Xu, Joy C Yang, Christopher Nip, Leyi Wang, Yuqiu Shen, Shu Ning, Yufeng Shang, Eva Corey, Allen C Gao, Jason E Gestwicki, Qiang Wei, Liangren Liu, Chengfei Liu
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Oncogene (2024)
Bo Chen, Pengfei Xu, Joy C Yang, Christopher Nip, Leyi Wang, Yuqiu Shen, Shu Ning, Yufeng Shang, Eva Corey, Allen C Gao, Jason E Gestwicki, Qiang Wei, Liangren Liu, Chengfei Liu
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Oncogene 43 (30) (2024)
Bo Chen, Pengfei Xu, Joy C Yang, Christopher Nip, Leyi Wang, Yuqiu Shen, Shu Ning, Yufeng Shang, Eva Corey, Allen C Gao, Jason E Gestwicki, Qiang Wei, Liangren Liu, Chengfei Liu
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Oncogene (2024)
Jinjiang Jiang, Bo Chen, Bo Tang, Jie Yang, Ting Zhang, Jinze Li, Daqing Tan, Qiang Wei
Trends of Prostate Cancer Morbidity in Low-Incidence Countries from 1990-2019. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (2) (2024)
Shiyu Zhang, Tianhai Lin, Xingyu Xiong, Chong Chen, Ping Tan, Qiang Wei
Targeting histone modifiers in bladder cancer therapy - preclinical and clinical evidence. Nature reviews. Urology (2024)
Shiyu Zhang, Tianhai Lin, Xingyu Xiong, Chong Chen, Ping Tan, Qiang Wei
Targeting histone modifiers in bladder cancer therapy - preclinical and clinical evidence. Nature reviews. Urology 21 (8) (2024)
Jinjiang Jiang, Bo Chen, Bo Tang, Jie Yang, Ting Zhang, Jinze Li, Daqing Tan, Qiang Wei
Trends of Prostate Cancer Morbidity in Low-Incidence Countries from 1990-2019. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (2) (2024)
Chichen Zhang, Xiang Tu, Jindong Dai, Zilong Zhang, Chenlan Shen, Qiyou Wu, Zhenhua Liu, Tianhai Lin, Shi Qiu, Lu Yang, Ling Yang, Mengni Zhang, Diming Cai, Yige Bao, Hao Zeng, Qiang Wei
Utilization trend of prebiopsy multiparametric magnetic resonance imaging and its impact on prostate cancer detection: Real-world insights from a high-volume center in southwest China. The Prostate 84 (6) (2024)
Feng Wen, Tianhai Lin, Peng Zhang, Hao Zeng, Qiang Wei, Yali Shen
Bladder sparing by short-course radiotherapy combined with toripalimab in high-risk/extremely high-risk non-muscle invasive bladder cancer (HOPE-04): study protocol for a single-arm, prospective, phase II trial. BMJ open 14 (1) (2024)
Feng Wen, Tianhai Lin, Peng Zhang, Hao Zeng, Qiang Wei, Yali Shen
Bladder sparing by short-course radiotherapy combined with toripalimab in high-risk/extremely high-risk non-muscle invasive bladder cancer (HOPE-04): study protocol for a single-arm, prospective, phase II trial. BMJ open 14 (1) (2024)
Chichen Zhang, Xiang Tu, Jindong Dai, Zilong Zhang, Chenlan Shen, Qiyou Wu, Zhenhua Liu, Tianhai Lin, Shi Qiu, Lu Yang, Ling Yang, Mengni Zhang, Diming Cai, Yige Bao, Hao Zeng, Qiang Wei
Utilization trend of prebiopsy multiparametric magnetic resonance imaging and its impact on prostate cancer detection: Real-world insights from a high-volume center in southwest China. The Prostate 84 (6) (2024)
Chengfei Liu, Bo Chen, Pengfei Xu, Joy C Yang, Christopher Nip, Leyi Wang, Yuqiu Shen, Shu Ning, Yufeng Shang, Eva Corey, Allen C Gao, Jason E Gestwicki, Qiang Wei, Liangren Liu
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Research square (2024)
Chengfei Liu, Bo Chen, Pengfei Xu, Joy C Yang, Christopher Nip, Leyi Wang, Yuqiu Shen, Shu Ning, Yufeng Shang, Eva Corey, Allen C Gao, Jason E Gestwicki, Qiang Wei, Liangren Liu
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Research square (2024)
Chengfei Liu, Bo Chen, Pengfei Xu, Joy C Yang, Christopher Nip, Leyi Wang, Yuqiu Shen, Shu Ning, Yufeng Shang, Eva Corey, Allen C Gao, Jason E Gestwicki, Qiang Wei, Liangren Liu
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Research square (2024)
Bo Chen, Pengfei Xu, Joy C Yang, Christopher Nip, Leyi Wang, Yuqiu Shen, Shu Ning, Yufeng Shang, Eva Corey, Allen C Gao, Jason E Gestwicki, Qiang Wei, Liangren Liu, Chengfei Liu
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Oncogene (2024)
Jinjiang Jiang, Bo Chen, Bo Tang, Jie Yang, Ting Zhang, Jinze Li, Daqing Tan, Qiang Wei
Trends of Prostate Cancer Morbidity in Low-Incidence Countries from 1990-2019. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (2) (2024)
Feng Wen, Tianhai Lin, Peng Zhang, Hao Zeng, Qiang Wei, Yali Shen
Bladder sparing by short-course radiotherapy combined with toripalimab in high-risk/extremely high-risk non-muscle invasive bladder cancer (HOPE-04): study protocol for a single-arm, prospective, phase II trial. BMJ open 14 (1) (2024)
Chengfei Liu, Bo Chen, Pengfei Xu, Joy C Yang, Christopher Nip, Leyi Wang, Yuqiu Shen, Shu Ning, Yufeng Shang, Eva Corey, Allen C Gao, Jason E Gestwicki, Qiang Wei, Liangren Liu
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. Research square (2024)
Hang Xu, Tianhai Lin, Jianzhong Ai, Jiapeng Zhang, Shiyu Zhang, Yifan Li, Xiaonan Zheng, Peng Zhang, Qiang Wei, Ping Tan, Lu Yang
Utilizing the Lactate Dehydrogenase-to-Albumin Ratio for Survival Prediction in Patients with Bladder Cancer After Radical Cystectomy. Journal of inflammation research 16 (2023)
Hang Xu, Tianhai Lin, Jianzhong Ai, Jiapeng Zhang, Shiyu Zhang, Yifan Li, Xiaonan Zheng, Peng Zhang, Qiang Wei, Ping Tan, Lu Yang
Utilizing the Lactate Dehydrogenase-to-Albumin Ratio for Survival Prediction in Patients with Bladder Cancer After Radical Cystectomy. Journal of inflammation research 16 (2023)
Hang Xu, Tianhai Lin, Jianzhong Ai, Jiapeng Zhang, Shiyu Zhang, Yifan Li, Xiaonan Zheng, Peng Zhang, Qiang Wei, Ping Tan, Lu Yang
Utilizing the Lactate Dehydrogenase-to-Albumin Ratio for Survival Prediction in Patients with Bladder Cancer After Radical Cystectomy. Journal of inflammation research 16 (2023)
Jie Yang, Xingyu Xiong, Weitao Zheng, Xinyang Liao, Hang Xu, Lu Yang, Qiang Wei
Combining Novel Hormonal Therapies with a Poly (ADP-Ribose) Polymerase Inhibitor for Metastatic Castration-Resistant Prostate Cancer: Emerging Evidence. Current oncology (Toronto, Ont.) 30 (12) (2023)
Jie Yang, Xingyu Xiong, Weitao Zheng, Xinyang Liao, Hang Xu, Lu Yang, Qiang Wei
Combining Novel Hormonal Therapies with a Poly (ADP-Ribose) Polymerase Inhibitor for Metastatic Castration-Resistant Prostate Cancer: Emerging Evidence. Current oncology (Toronto, Ont.) 30 (12) (2023)
Ruopeng Su, Liangren Liu, Daoping Hong, Shuai Jiang, Yichu Yuan, Xingyun Cai, Hai-Long Hu, Changde Fu, Zhiyang Huang, Zhenyu Wang, Bing Zheng, Jian Huang, Zaoyu Wang, Yige Bao, Ming Cai, Jianming Guo, Minfeng Chen, Qiang Wei, Jiwei Huang, Wei Xue
Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world study. Cancer medicine (2023)
Hang Xu, Tianhai Lin, Jianzhong Ai, Jiapeng Zhang, Shiyu Zhang, Yifan Li, Xiaonan Zheng, Peng Zhang, Qiang Wei, Ping Tan, Lu Yang
Utilizing the Lactate Dehydrogenase-to-Albumin Ratio for Survival Prediction in Patients with Bladder Cancer After Radical Cystectomy. Journal of inflammation research 16 (2023)
Jie Yang, Xingyu Xiong, Weitao Zheng, Xinyang Liao, Hang Xu, Lu Yang, Qiang Wei
Combining Novel Hormonal Therapies with a Poly (ADP-Ribose) Polymerase Inhibitor for Metastatic Castration-Resistant Prostate Cancer: Emerging Evidence. Current oncology (Toronto, Ont.) 30 (12) (2023)
Jie Yang, Xingyu Xiong, Weitao Zheng, Xinyang Liao, Hang Xu, Lu Yang, Qiang Wei
Combining Novel Hormonal Therapies with a Poly (ADP-Ribose) Polymerase Inhibitor for Metastatic Castration-Resistant Prostate Cancer: Emerging Evidence. Current oncology (Toronto, Ont.) 30 (12) (2023)
Jianjun Ye, Qiyou Wu, Xinyang Liao, Lei Zheng, Qiang Wei, Yige Bao
Advanced Age May Not Be an Absolute Contraindication for Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma: A Single-Center Case Series and a Systematic Review with Meta-Analyses. Journal of clinical medicine 12 (23) (2023)
Jinjiang Jiang, Bo Chen, Bo Tang, Qiang Wei
Selenium in Prostate Cancer: Prevention, Progression, and Treatment. Pharmaceuticals (Basel, Switzerland) 16 (9) (2023)
Jie Yang, Xingyu Xiong, Weitao Zheng, Xinyang Liao, Hang Xu, Lu Yang, Qiang Wei
Combining Novel Hormonal Therapies with a Poly (ADP-Ribose) Polymerase Inhibitor for Metastatic Castration-Resistant Prostate Cancer: Emerging Evidence. Current oncology (Toronto, Ont.) 30 (12) (2023)
Jinjiang Jiang, Jinze Li, Xingyu Xiong, Shiyu Zhang, Daqing Tan, Lu Yang, Qiang Wei
Different predictive values of microvessel density for biochemical recurrence among different PCa populations: A systematic review and meta-analysis. Cancer medicine (2022)
Zeyu Chen, Shi Qiu, Chichen Zhang, Yu Zhan, Liangren Liu, Yige Bao, Bo Chen, Yunjin Bai, Xiaonan Zheng, Yin Huang, Kun Jin, Ping Han, Qiang Wei
Association of urinary organophosphate esters level with sex steroid hormones levels in adult males: A nationwide study, NHANES 2013-2014. Andrology 10 (3) (2022)
Xiang Tu, Chichen Zhang, Qiang Wei
Re: Impact of mpMRI targeted biopsy on intraoperative nerve-sparing (NeuroSAFE) during robot-assisted laparoscopic radical prostatectomy. The Prostate 82 (8) (2022)
Hang Xu, Jiapeng Zhang, Xiaonan Zheng, Ping Tan, Xingyu Xiong, Xianyanling Yi, Yang Yang, Yan Wang, Dazhou Liao, Hong Li, Qiang Wei, Jianzhong Ai, Lu Yang
SR9009 inhibits lethal prostate cancer subtype 1 by regulating the LXRα/FOXM1 pathway independently of REV-ERBs. Cell death & disease 13 (11) (2022)
Weihua Zhuang, Ping Tan, Shufen Li, Chengming Li, Jiapeng Zhang, Jianzhong Ai, Lu Yang, Gaocan Li, Qiang Wei, Mao Chen, Yun-Bing Wang
A lipid droplet specific fluorescent probe for image-guided photodynamic therapy under hypoxia. Journal of materials chemistry. B 9 (46) (2021)
Ping Tan, Manli Wang, Ailing Zhong, Yiyun Wang, Jiajia Du, Jian Wang, Lu Qi, Zhanying Bi, Peng Zhang, Tianhai Lin, Jiapeng Zhang, Lu Yang, Jingyao Chen, Ping Han, Qi-Yong Gong, Yu Liu, Chong Chen, Qiang Wei
SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis. Oncogene 40 (42) (2021)
Haoran Lei, Ming Shi, Hang Xu, Shengjiang Bai, Xingyu Xiong, Qiang Wei, Lu Yang
Combined Treatment of Radiotherapy and Immunotherapy for Urological Malignancies: Current Evidence and Clinical Considerations. Cancer management and research 13 (2021)
Xianghong Zhou, Kun Jin, Shi Qiu, Qiuxiang Yang, Peng Wang, Yu Zhan, Xinyi Huang, Zhongyuan Jiang, Dan Hu, Lu Yang, Qiang Wei
Associations of exposure to polycyclic aromatic hydrocarbons and kidney stones in U.S. general population: results from the National Health and Nutrition Examination Survey 2007-2016. World journal of urology (2021)
Mingjing He, Kun Jin, Shi Qiu, Xinyang Liao, Xiaonan Zheng, Zeyu Chen, Jianzhong Ai, Lu Yang, Zhongyuan Jiang, Dan Hu, Qiang Wei
The associations between organophosphate esters and urinary incontinence in the general US population. Environmental science and pollution research international (2021)
Jing Zhou, Zheng-Huan Liu, De-Hong Cao, Zhu-Feng Peng, Pan Song, Luchen Yang, Liang-Ren Liu, Qiang Wei, Qiang Dong
Retroperitoneal or transperitoneal approach in robot-assisted partial nephrectomy, which one is better? Cancer medicine 10 (10) (2021)
Xingyuan Wang, Zeyu Chen, Shi Qiu, Dehong Cao, Kun Jin, Jin Li, Bo Chen, Yin Huang, Yige Bao, Liangren Liu, Qiang Wei
Evaluating the Effect of Cryptorchidism on Clinical Stage of Testicular Seminoma. Cancer management and research 12 (2020)
Xingyu Xiong, Shi Qiu, Xianyanling Yi, Kun Jin, Hang Xu, Hanran Lei, Shengjiang Bai, Ge Peng, Lu Yang, Qiang Wei
Effect of neurovascular bundle sparing radical cystectomy on post-operative continence and sexual function: A systematic review and meta-analysis. Andrology 9 (1) (2020)
Kexin Xie, Dehong Cao, Qiang Wei, Zhengju Ren, Jinze Li, Yunxiang Li, Meiling Fu
Bipolar versus monopolar transurethral resection of non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials. World journal of urology 39 (4) (2020)
Di Jin, Kun Jin, Shi Qiu, Xianghong Zhou, Qiming Yuan, Lu Yang, Qiang Wei
Prognostic values of the clinicopathological characteristics and survival outcomes in micropapillary urothelial carcinoma of the bladder: A SEER database analysis. Cancer medicine 9 (14) (2020)
Shi Qiu, Linghui Deng, Xinyang Liao, Ling Nie, Fang Qi, Kun Jin, Xiang Tu, Xiaonan Zheng, Jiakun Li, Liangren Liu, Zhenhua Liu, Yige Bao, Jianzhong Ai, Tianhai Lin, Lu Yang, Qiang Wei
Tumor-associated macrophages promote bladder tumor growth through PI3K/AKT signal induced by collagen. Cancer science 110 (7) (2019)
Xiaonan Zheng, Xin Han, Dehong Cao, Hang Xu, Lu Yang, Jianzhong Ai, Qiang Wei
Comparison between cold knife and laser urethrotomy for urethral stricture: a systematic review and meta-analysis of comparative trials. World journal of urology 37 (12) (2019)
Jiakun Li, Yaochuan Guo, Shi Qiu, Mingjing He, Kun Jin, Xiaonan Zheng, Xiang Tu, Xinyang Liao, Lu Yang, Qiang Wei
Significance of tertiary Gleason pattern 5 in patients with Gleason score 7 after radical prostatectomy: a retrospective cohort study. OncoTargets and therapy 12 (2019)
Wenbin Xue, Ping Tan, Hang Xu, Lu Yang, Qiang Wei
Impact of the preoperative prognostic nutritional index on survival outcomes in upper tract urothelial carcinomas. Cancer medicine 8 (6) (2019)
Kun Jin, Shi Qiu, Jiakun Li, Xiaonan Zheng, Xiang Tu, Xinyang Liao, Yan Yang, Lu Yang, Qiang Wei
How to choose proper local treatment in men aged ≥75 years with cT2 localized prostate cancer? Cancer medicine 8 (7) (2019)
Hang Xu, Ping Tan, Xi Jin, Jianzhong Ai, Tianhai Lin, Haoran Lei, Lu Yang, Qiang Wei
Validation of the preoperative controlling nutritional status score as an independent predictor in a large Chinese cohort of patients with upper tract urothelial carcinoma. Cancer medicine 7 (12) (2018)
Ping Tan, Jie Chen, Nan Xie, Hang Xu, Jianzhong Ai, Huan Xu, Liangren Liu, Lu Yang, Qiang Wei
Is preoperative serum lactate dehydrogenase useful in predicting the outcomes of patients with upper tract urothelial carcinoma? Cancer medicine 7 (10) (2018)
Xiaonan Zheng, Yuxuan Qiu, Shi Qiu, Liansha Tang, Kailei Nong, Xin Han, Min Li, Liuliu Quan, Lu Yang, Qiang Wei
Photoselective vaporization has comparative efficacy and safety among high-risk benign prostate hyperplasia patients on or off systematic anticoagulation: a meta-analysis. World journal of urology 37 (7) (2018)
Yi Sun, Lu Yang, Yige Bao, Zhenhua Liu, Liangren Liu, Qiang Wei
Efficacy of PDE5Is and SSRIs in men with premature ejaculation: a new systematic review and five meta-analyses. World journal of urology 35 (12) (2017)